Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07351253

Erector Spinae Plane Block Versus Lateral Transversus Abdominis Plane Block for Open Abendectomy Surgery

Analgeisc Effect of Erector Spinae Plane Block Versus Lateral Transversus Abdominis Plane Block in Patients Undergoing Open Abendectomy Surgery: a Randomized Controlled Trial

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
68 (estimated)
Sponsor
Cairo University · Academic / Other
Sex
All
Age
21 Years
Healthy volunteers
Not accepted

Summary

this aim of this study is to compare the analgesic effect of Erector spinae plane (ESP) block and lateral transversus abdominis plan (TAP) block in patients undergoing open appendectomy.

Detailed description

regional technique according to randomization will be given after induction of general anesthesia Fentanyl boluses of 1 mcg/kg will be given in case of inadequate analgesia. Inadequate analgesia identified by 20% increase in the heart rate and/or systolic blood pressure from baseline measurement. postoperative analgesia: regular paracetamol 1 g/6 hours (intravenously at first then orally once the oral feeding is resumed) and 75 mg diclofenac (intramuscularly at first then orally once the oral feeding is resumed). If Numeric rating scale (NRS) is \> 3 intravenous titration of 2 mg morphine is given slowly to be repeated after 30 minutes if pain persisted

Conditions

Interventions

TypeNameDescription
OTHERErector Spinae Plane BlockPatients will receive the ESP block at the level of the 10th thoracic (T10) transverse process using a linear 6-13 MHz ultrasound transducer. A 20 mL of 0.25% bupivacaine will be injected below the muscle
OTHERTransversus abdominis plane (TAP) blockPatient will received TAP block using the lateral approach while in supine position. A 20 mL of 0.25% bupivacaine will be injected after negative aspiration.

Timeline

Start date
2026-01-25
Primary completion
2026-05-01
Completion
2026-05-01
First posted
2026-01-20
Last updated
2026-03-17

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT07351253. Inclusion in this directory is not an endorsement.